Neogen

Recent news

• Rating change
  Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $13
  Market Newswire · 2026/8/3
• Company notice
  Neogen | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Ranalli Tamara A.
  SEC · 2026/1/29
• Rating change
  Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Raises Target Price to $12
  Market Newswire · 2026/1/9
• Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Biosciences, Inc. Class A (SGMT)
  TipRanks · 2026/9/28
• Rating change
  Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Maintains Target Price $5
  Market Newswire · 2025/8/4
• Company notice
  Neogen | 3: Initial statement of beneficial ownership of securities-Officer Ranalli Tamara A.
  SEC · 2026/1/26
• Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Raises Target Price to $14
  Market Newswire · 2026/9/30
• Piper Sandler Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $14
  Market Newswire · 2026/9/15
• Rating change
  Analysts Conflicted on These Healthcare Names: Neogen (NEOG), Pfizer (PFE) and Hinge Health, Inc. Class A (HNGE)
  TipRanks · 2026/7/30
• Rating change
  Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $12
  Market Newswire · 2026/7/31
• Piper Sandler Upgrades Neogen(NEOG.US) to Buy Rating, Raises Target Price to $14
  Market Newswire · 2026/8/26
• Company notice
  Neogen | 4: Statement of changes in beneficial ownership of securities-Officer Naemura David H.
  SEC · 2025/12/3
• Rating change
  CJS Securities Upgrades Neogen(NEOG.US) to Buy Rating, Maintains Target Price $10
  Market Newswire · 2025/12/10
• Rating change
  CJS Securities Initiates Neogen(NEOG.US) With Hold Rating, Announces Target Price $10
  Market Newswire · 2025/9/29
• Company notice
  Neogen | 4: Statement of changes in beneficial ownership of securities-Officer Naemura David H.
  SEC · 2025/10/29
• Rating change
  Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $6.5
  Market Newswire · 2025/10/16
• William Blair Maintains Neogen(NEOG.US) With Hold Rating
  Market Newswire · 2026/9/28
• Company notice
  Neogen | 4: Statement of changes in beneficial ownership of securities-Officer Ranalli Tamara A.
  SEC · 2026/1/26
• Rating change
  Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $10
  Market Newswire · 2026/1/13
• Rating change
  Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Cuts Target Price to $8
  Market Newswire · 2025/10/10

Headlines are aggregated automatically and are not independently verified or edited by our team.